Axordia

Axordia Limited researches human stem cells to develop treatments for debilitating diseases such as heart disease, liver failure, Parkinson's disease, and multiple sclerosis. The company, formerly known as Cellbiosys Limited, was renamed Axordia Limited in May 2001. Founded in 1999, the company is headquartered in Sheffield, UK. As of December 22, 2008, Axordia Limited operates as a subsidiary of Intercytex Group Plc.